Emergent BioSolutions (EBS) Misses Q1 EPS by 65c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.44 -5.43%
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
IEP, XPRO, GEF, More
Financial Fact:
Earnings per share - basic: 0.52
Today's EPS Names:
IEP, XPRO, GEF, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.21, $0.65 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $156.1 million versus the consensus estimate of $205 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Reiterated at Market Outperform by Citizens - 'One of the Best Deep-Value Stories'
- Grab Holdings (GRAB) Misses Q3 EPS by 5c; raises guidance
- WISeQey posts 55% revenue growth, reaffirms full-year guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
